ASTEC.NS
Astec Lifesciences Ltd
Price:  
945 
INR
Volume:  
114,499
India | Chemicals

ASTEC.NS WACC - Weighted Average Cost of Capital

The WACC of Astec Lifesciences Ltd (ASTEC.NS) is 13.0%.

The Cost of Equity of Astec Lifesciences Ltd (ASTEC.NS) is 15.45%.
The Cost of Debt of Astec Lifesciences Ltd (ASTEC.NS) is 6.8%.

RangeSelected
Cost of equity12.7% - 18.2%15.45%
Tax rate25.1% - 26.2%25.65%
Cost of debt6.6% - 7.0%6.8%
WACC10.9% - 15.2%13.0%
WACC

ASTEC.NS WACC calculation

CategoryLowHigh
Long-term bond rate6.9%7.4%
Equity market risk premium8.3%9.3%
Adjusted beta0.71.11
Additional risk adjustments0.0%0.5%
Cost of equity12.7%18.2%
Tax rate25.1%26.2%
Debt/Equity ratio
0.30.3
Cost of debt6.6%7.0%
After-tax WACC10.9%15.2%
Selected WACC13.0%

ASTEC.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for ASTEC.NS:

cost_of_equity (15.45%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.7) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.